RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS (RAASI) AND CLINICAL OUTCOMES IN HEMODIALYSIS PATIENTS: RESULTS FROM THE DOPPS

被引：0

作者：

Karaboyas, Angelo ^{[2
]}

Morgenstern, Hal ^{[2
,6
]}

Xu, Hairong ^{[3
]}

Ashfaq, Akhtar ^{[3
]}

Jadoul, Michel ^{[5
]}

Locatelli, Francesco ^{[1
]}

Nitta, Kosaku ^{[4
]}

Tentori, Francesca ^{[2
,8
]}

Robinson, Bruce ^{[2
,7
]}

机构：

[1] Alessandro Manzoni Hosp, Nephrol, Lecce, Italy

[2] Dopps Arbor Res Collaborat Hlth, Ann Arbor, MI USA

[3] AstraZeneca, Global Med Affairs, Gaithersburg, MD USA

[4] Tokyo Womens Med Univ, Dept Med, Tokyo, Japan

[5] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium

[6] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA

[7] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA

[8] Vanderbilt Univ, Med Ctr, Nephrol, Nashville, TN USA

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

SP551

引用

页数：1

共 50 条

[21] Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
Palmer, BF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06): : 585 - 592
[22] Renin-angiotensin-aldosterone system inhibitors and COVID-19
Quinn, Kieran L.
Fralick, Michael
Zipursky, Jonathan S.
Stall, Nathan M.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (20) : E553 - E554
[23] Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19
Birnbaum, Ron A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24):
[24] COVID-19 and inhibitors of the renin-angiotensin-aldosterone system
Hussain, Musaddique
Jabeen, Qaiser
Ahmad, Fiaz-Ud-Din
Kashif-Ur-Rehman
Fatima, Mobeen
Shaukat, Saira
Majeed, Abdul
Barkat, Muhammad Qasim
Wu, Ximei
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (07) : 815 - 816
[25] New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Overview of Regulation of the Renin-Angiotensin-Aldosterone System
Nishiyama, Akira
Kim-Mitsuyama, Shokei
[J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 113 (04) : 289 - 291
[26] Renin-Angiotensin-Aldosterone System Blockade in Diabetes: Role of Direct Renin Inhibitors
Estacio, Raymond O.
[J]. POSTGRADUATE MEDICINE, 2009, 121 (03) : 33 - 44
[27] Implications of hyperkalemia in the management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes
Santiago Jimenez-Marrero, S.
Cainzos-Achirica, M.
Monterde, D.
Enjuanes, C.
Alcoberro, L.
Garay, A.
Yun, S.
Moliner, P.
Ramos, R.
Ras, M.
Jose, N.
Hidalgo, E.
Calero, E.
Corbella, X.
Comin-Colet, J.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 64 - 65
[28] The Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Outcomes of Patients Treated with Immune Checkpoint Inhibitors: a Retrospective Cohort Study
Chiang, C. H.
Wang, S. S.
Chang, Y. C.
Chiang, C. H.
Chen, C. Y.
Chen, Y. J.
See, X. Y.
Peng, C. Y.
Hsia, Y. P.
Chiang, C. H.
Peng, C. M.
[J]. CLINICAL ONCOLOGY, 2023, 35 (07) : 446 - 453
[29] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN PHEOCHROMOCYTOMA
SAGAT, T
SASINKA, M
ZVARA, V
PECHAN, J
BLAZICEK, J
[J]. INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1981, 2 (04): : 288 - 288
[30] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSION
STREETEN, DH
CLIFT, GV
SCHLETTE.FE
DALAKOS, TS
[J]. ANNALS OF INTERNAL MEDICINE, 1968, 68 (05) : 1164 - +

← 1 2 3 4 5 →